Short-Term Erythropoietin Treatment Does Not Substantially Modulate Monocyte Transcriptomes of Patients with Combined Heart and Renal Failure

BACKGROUND: Combined heart and renal failure is associated with high cardiovascular morbidity and mortality. Anti-oxidant and anti-inflammatory, non-hematopoietic effects of erythropoietin (EPO) treatment have been proposed. Monocytes may act as biosensors of the systemic environment. We hypothesize...

Descripción completa

Detalles Bibliográficos
Autores principales: Jie, Kim E., van der Putten, Karien, Wesseling, Sebastiaan, Joles, Jaap A., Bergevoet, Marloes W., Pepers-de Kort, Floor, Doevendans, Pieter A., Yasui, Yutaka, Liu, Qi, Verhaar, Marianne C., Gaillard, Carlo A., Braam, Branko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3434212/
https://www.ncbi.nlm.nih.gov/pubmed/22957013
http://dx.doi.org/10.1371/journal.pone.0041339

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3434212/
https://www.ncbi.nlm.nih.gov/pubmed/22957013
http://dx.doi.org/10.1371/journal.pone.0041339

Ejemplares similares